Protagonist Therapeutics, Inc (PTGX) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for PTGX. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 334 institutions reported holding PTGX, with 75.8 million shares worth $9.3 billion in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| BlackRock | 10,307,837 | $1.3B | INCREASED |
| Vanguard | 7,019,174 | $860M | INCREASED |
| Farallon Capital Management | 6,348,906 | $778M | UNCHANGED |
| Rtw Investments | 5,061,175 | $620M | INCREASED |
| UBS Group | 3,506,315 | $430M | DECREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Asif Ali (Chief Financial Officer) | EXERCISE | 5,312 | $65K | 2026-09-30 |
| Asif Ali (Chief Financial Officer) | EXERCISE | 15,650 | $300K | 2026-09-30 |
| Asif Ali (Chief Financial Officer) | EXERCISE | 28,438 | $666K | 2026-09-30 |
| Asif Ali (Chief Financial Officer) | EXERCISE | 9,229 | $360K | 2026-09-30 |
| Asif Ali (Chief Financial Officer) | SELL | 46,034 | $7M | 2026-09-30 |
Full institutional holdings, insider history, and congressional trades for Protagonist Therapeutics, Inc on SentiSense.